Advertisement
Experimental Therapeutics

Multimodality Therapy with a Replication-conditional Herpes Simplex Virus 1 Mutant that Expresses Yeast Cytosine Deaminase for Intratumoral Conversion of 5-Fluorocytosine to 5-Fluorouracil

Hideo Nakamura, John T. Mullen, Soundararajalu Chandrasekhar, Timothy M. Pawlik, Sam S. Yoon and Kenneth K. Tanabe
DOI:  Published July 2001

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: July 2001 to April 2021

AbstractFull-text HTMLPDF
Total121424621350

Cited By

Article Information

Volume 61, Issue 14, pp. 5447-5452

PubMed 
11454690
Published By 
American Association for Cancer Research
Print ISSN 
0008-5472
Online ISSN 
1538-7445
History 
  • Received February 14, 2001
  • Accepted May 16, 2001
  • Published first July 1, 2001.
Copyright & Usage 
©2001 American Association for Cancer Research.

Author Information

  1. Hideo Nakamura,
  2. John T. Mullen,
  3. Soundararajalu Chandrasekhar,
  4. Timothy M. Pawlik,
  5. Sam S. Yoon, and
  6. Kenneth K. Tanabe2
  1. Division of Surgical Oncology and Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114
View Full Text
Back to top
Cancer Research: 61 (14)
July 2001
Volume 61, Issue 14

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Email Article
Citation Tools
Multimodality Therapy with a Replication-conditional Herpes Simplex Virus 1 Mutant that Expresses Yeast Cytosine Deaminase for Intratumoral Conversion of 5-Fluorocytosine to 5-Fluorouracil
Hideo Nakamura, John T. Mullen, Soundararajalu Chandrasekhar, Timothy M. Pawlik, Sam S. Yoon and Kenneth K. Tanabe
Cancer Res July 15 2001 (61) (14) 5447-5452;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section

Advertisement